A dose eficaz de bevacizumab para o tratamento da retinopatia da prematuridadeA dose eficaz de bevacizumab para o tratamento da retinopatia da prematuridade

摘要

Dear Editor,We read, with great interest, the article entitled "Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?" by Dikci et al.(1). In the article, the authors compared 0.625 mg vs 0.5 mg intravitreal bevacizumab injection in patients with aggressive posterior retinopathy of prematurity (ROP). They concluded that the lower dose (0.5 mg) may require additional treatment compared with the 0.625 mgdose regimen. However, we have some comments with regard to this article.